CVS to open new Kansas City distribution center
KANSAS CITY, Mo. — Kansas City, here CVS comes.
The Kansas City Development Council announced Wednesday that CVS Pharmacy will build a 762,000-square-foot distribution center at Kansas City’s Skyport Industrial Park. A ground breaking for the 71-acre facility, located at 108th Street and North Congress near Kansas City International Airport and Interstate 29, is expected to take place in January, and construction is expected to commence immediately.
The new distribution center is expected to open in 2018 and support the service and fulfillment needs of more than 370 CVS Pharmacy stores throughout the Midwest. The new facility is expected to create more than 360 new jobs, as well as 100 additional jobs that will outsourced to local businesses.
“The key combination of a high-quality workforce and a centralized location will support the growing needs of our customers throughout the Midwest and beyond,” said Kevin Hourican, executive VP, Pharmacy Services and Supply Chain, CVS Health. “As a result of our new Midwest distribution center, our delivery drivers will drive hundreds of thousands fewer miles each year to deliver product to our stores, significantly reducing carbon emissions and improving highway safety.”
The new facility is expected to create more than 360 new jobs, as well as 100 additional jobs that will outsourced to local businesses.
“On behalf of CVS Pharmacy, we are thrilled to grow our presence in the Kansas City business community. This new location will help us better support our expanding distribution needs in the Midwestern market,” said Ron Link, Senior Vice President of Logistics at CVS/pharmacy. “We want to thank state and local officials for their cooperation and support during our site selection process.”
Tim Cowden, president and CEO of the Kansas City Area Development Council, told Drug Store News the selection process took CVS approximately one year, with the Woonsocket, R.I.-based retailer also considering other Midwestern locales for its new distribution center.
“CVS selected Kansas City for its ability to reach a big grouping of its customers,” said Cowden. “We’re very happy a company with the brand power of CVS chose Kansas City, which is emerging as a tier-one logistics center.”
Naloxone now available without a prescription at all CVS Pharmacy locations in Nevada
WOONSOCKET, R.I. — Naloxone is now available without a prescription at all CVS Pharmacy locations in Nevada. The Woonsocket-based company stated it established a standing order with physicians in the Sliver State that allows CVS Pharmacy to expand access to the medication across the state.
"Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our Nevada pharmacies by the use of a physician's standing order for patients without a prescription, we can help save lives," said Tom Davis, RPh, VP of Pharmacy Professional Practices at CVS Pharmacy. "We are dedicated to helping the communities we serve address and prevent drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery."
According to CVS Health, the move to expand access to naloxone builds on its longstanding commitment to help communities address and prevent drug abuse through education, outreach and safe medication disposal. CVS Health's commitment to drug abuse prevention education extends from online resources for patientes visiting CVS.com to a commitment to youth prevention programs. Launched in 2015, CVS Health's Pharmacists Teach program gives its pharmacists the opportunity to volunteer to speak to local students about the dangers of drug abuse. More than 150,000 students have already been part of the program. The CVS Health Foundation is also working with DoSomething.org to create a peer-to-peer prevention and intervention program delivered to young people via text message and online.
In addition, CVS Health joined with the Partnership for Drug-Free Kids to create the Medication Disposal for Safer Communities Program, which has donated more than 600 drug disposal units to police departments around the country.
"CVS Health has been a leader in the work of helping communities prevent prescription drug abuse," said Marcia Lee Taylor, president and CEO, Partnership for Drug-Free Kids. "In addition to proper disposal of unwanted medication, increasing access to naloxone is a critical public health priority that allows patients and their families to prevent opioid fatalities and recognize when people need help working towards recovery from the disease of addiction."
CVS Health now dispenses naloxone in 37 states.
Health Dialog’s ‘right person, right time’ solutions earn Frost & Sullivan recognition
MOUNTAIN VIEW, Calif. — Based on its recent analysis of the patient shared decision-making market, Frost & Sullivan on Tuesday recognized Rite Aid's Health Dialog with the 2016 North American Frost & Sullivan Award for Product Leadership.
“The company’s comprehensive SDM tools and capabilities, combined with its integrated suite of population health tools, are unique in the industry," stated Nancy Fabozzi, principal analyst Frost & Sullivan. "According to the population’s requirements, Health Dialog’s clients can implement either a comprehensive and tailored SDM program or just specific components,” she said. “The company designs cost-effective patient education and engagement strategies and ensures they are relevant to every patient across disease stages and population segments, facilitating consistent and efficient decision making.”
"Shared decision making is an essential tool to engage and educate patients and a cornerstone of Health Dialog's total population health management solutions," stated Web Golinkin, CEO Health Dialog, in accepting the recognition.
Health Dialog is a market leader in SDM, Frost & Sullivan noted, having pioneered integrated, customized, white-label decision-making solutions across the healthcare industry. Its unique SDM program comprises proprietary, advanced analytics; educational medical content and decision aids; as well as multi-channel coaching strategies. These elements drive value-based patient SDM to help enhance outcomes and lower costs of care for customers.
Health Dialog offers a suite of integrated total population health management services to help reduce costs and increase quality of care for its customer base of health plans, self-insured employers and providers.
Its SDM program has three core components:
- Predictive analytics: This technology employs proprietary, advanced, modular analytics to stratify populations into nine disease stages, from well to recovery, and predicts risk of condition progression across the entire population segment. Based on these ‘Care Pathways,’ Health Dialog tailors intervention strategies, including modality and outreach, in line with clients’ clinical and economic goals;
- Evidence-based medical decision aids: Best-in-class content covers 38 health topics and explains test, treatment, and care options for chronic and preference-sensitive conditions. Available online, in print and in DVD formats, these decision aids are easily accessible, easy-to-use, and feature the experiences of real people who have faced a treatment decision or are managing a condition; and
- Health coaching: Multi-channel strategies connect patients and members with health coaches via digital platforms as well as by phone, mail, text message, and face-to-face meetings. The expert team comprises nurses, dietitians, respiratory therapists, lifestyle coaches, and pharmacists with experience in behavior change methodologies and motivational coaching.
Health Dialog drew upon its experience in the market to launch its Health Dialog Interact™ Personal Health Portal. This portal helps risk-bearing organizations engage their entire population, not just the unwell, to lead healthier lives. The middle segment of the population, which is neither sick nor well but has pre-conditions, accounts for 53% of an organization’s healthcare costs. The Health Dialog Interact Portal aims to guide the largest possible group of members to better health.
The Health Dialog Interact Personal Health Portal is powered by Health Dialog’s proprietary analytics engine, the Care Pathways models, which categorize individuals under one of the nine stages of wellness beginning with ‘well’ and progressing through ‘at risk,’ ‘condition onset’ and ‘sentinel stage,’ and ending with ‘recovery.’ By establishing the individual’s position on the pathway, Care Pathways’ robust analytics makes communication and engagement strategies more personalized and thus effective.
“Through the Health Dialog Interact Portal’s multi-channel communications capabilities, organizations can deliver all of Health Dialog’s assets — health coaching, SDM, care management programs and wellness tools — to the right person, at the right time,” noted Fabozzi. “Additionally, the portal links various company assets that leverage SDM components to support medication compliance, which can greatly reduce healthcare costs.”
Overall, Health Dialog’s SDM offerings, as well as its new Health Dialog Interact Personal Health Portal, present payers and providers with a comprehensive, integrated, and modular platform that promote better patient engagement, helping them transition toward value-based care and reimbursement.
Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality, gaining rapid acceptance in the market. The award recognizes the quality of the solution and the customer value enhancements it enables.